Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04659629 |
| Title | NL-201 in Patients With Relapsed or Refractory Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Neoleukin Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | New York | New York | 10021 | United States | Details | |
| Providence Cancer Center Oncology and Hematology Care Clinic | Portland | Oregon | 97213 | United States | Details | |
| UT- MD Anderson | Houston | Texas | 77230 | United States | Details | |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109 | United States | Details | |
| Melanoma Institute Australia | Sydney | New South Wales | 2065 | Australia | Details | |
| St Vincents Hospital | Sydney | New South Wales | Australia | Details | ||
| Olivia Newton-John Cancer Wellness & Research Centre | Heidelberg | Victoria | Australia | Details | ||
| UHN - Princess Margaret Cancer Center | Toronto | Ontario | M5G1Z5 | Canada | Details |